GlassScriptPhysician profile
Eric P Griffin
NPI 1356338701
$950.75
in general payments reported to CMS, 2019-2025
19 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $112 · 2021: $176 · 2022: $196 · 2023: $106 · 2024: $86.18 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $301 · Education: $61.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.12 |
| Education | $61.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $193.72 | 2020-2025 | |
| Astellas Pharma US INC | $139.59 | 2020-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $134.64 | 2021-2024 | |
| Hologic Sales and Service, LLC | $85.45 | 2019-2025 | Novasure, Myosure Tissue Removal Device |
| Daiichi Sankyo INC. | $74.98 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.39 | 2022-2025 | |
| Boston Scientific Corporation | $40.71 | 2019-2023 | Solyx Sis System |
| Allergan, INC. | $35.44 | 2019 | |
| Sumitomo Pharma America, INC. | $33.05 | 2024-2025 | Myfembree, Gemtesa |
| Merck Sharp & Dohme LLC | $26.71 | 2020 | |
| Mayne Pharma Commercial LLC | $21.25 | 2025 | |
| Axonics, INC. | $18.62 | 2024 | Axonics, Bulkamid |
| Agile Therapeutics, INC. | $18.39 | 2022 | |
| Myovant Sciences INC. | $15.86 | 2021 | |
| Organon LLC | $15.84 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $15.58 | 2025 | Cologuard Collection Kit |
| Exeltis, USA INC. | $13.71 | 2024 | Slynd |
| Amgen INC. | $13.23 | 2023 | Evenity, Prolia |
| Coloplast Corp | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.